![Garratt W. Ponder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Garratt W. Ponder
Corporate Officer/Principal bei
Tikvah Therapeutics, Inc.
Profil
Garratt W.
Ponder is Vice President of Pharmaceutical Development for Tikvah Therapeutics, Inc. Prior to joining Tikvah Therapeutics, he was Senior Director of Product Development for AtheroGenics, Inc. Before joining AtheroGenics in 2003, he worked at Endeavor Pharmaceuticals, Inc. and Solvay Pharmaceuticals, Inc. He has over 12 years of experience in analytical chemistry, process chemistry, and pharmaceutical development.
Dr. Ponder received a BS degree in Chemistry in 1989 and a PhD in Pharmaceutical Analysis from the University of Georgia in 1995.
Aktive Positionen von Garratt W. Ponder
| Unternehmen | Position | Beginn |
|---|---|---|
Tikvah Therapeutics, Inc.
 Tikvah Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutic products | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Garratt W. Ponder
| Unternehmen | Position | Ende |
|---|---|---|
Endeavor Pharmaceuticals, Inc.
 Endeavor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures hormone replacement pharmaceutical products | Corporate Officer/Principal | - |
Solvay Pharmaceuticals, Inc.
 Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Corporate Officer/Principal | - |
Ausbildung von Garratt W. Ponder
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
93
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
Endeavor Pharmaceuticals, Inc.
Endeavor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures hormone replacement pharmaceutical products | Health Technology |
Tikvah Therapeutics, Inc.
Tikvah Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutic products | Health Technology |
Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Georgia
 University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
